Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT-Reference-Cited by-同舟云学术

Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT

Published:2014-06-24 Issue:7 Volume:16 Page:810-816
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Komajda Michel¹,Böhm Michael²,Borer Jeffrey S³,Ford Ian⁴,Robertson Michele⁴,Manolis Athanasios J.⁵,Tavazzi Luigi⁶,Swedberg Karl⁷,

Affiliation:

1. Institute of Cardiometabolism and Nutrition (ICAN); Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital; Paris France

2. Universitätskliniken des Saarlandes; Klinik für Innere Medizin III; Homburg/Saar Germany

3. Division of Cardiovascular Medicine and the Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Translational Research; State University of New York Downstate Medical Center; New York NY USA

4. Robertson Centre for Biostatistics; University of Glasgow; Glasgow UK

5. Asklepeion Hospital; Athens Greece

6. Maria Cecilia Hospital; GVM Care and Research, Ettore Sansavini Health Science Foundation; Cotignola Italy

7. Department of Molecular and Clinical Medicine; Sahlgrenska Academy, University of Gothenburg; Göteborg Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.114/fullpdf

Reference24 articles.

1. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure;Gheorghiade;Heart Fail Rev,2013

2. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial;Ambrosy;Am Heart J,2013

3. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure;Banach;Am J Cardiol,2011

4. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program;Meredith;J Am Coll Cardiol,2008

5. Relation of systolic blood pressure to survival in both ischemic and nonischemic systolic heart failure;Cheng;Am J Cardiol,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of guideline‐directed medical therapy on systolic blood pressure and cardiovascular outcomes in patients with heart failure and low blood pressure: A systematic review and meta‐analysis;European Journal of Heart Failure;2024-04-12

2. Ivabradine: sinus rhythm control in heart failure;Pathophysiology, Risk Factors, and Management of Chronic Heart Failure;2024

3. Ivabradine in patients with heart failure: a systematic literature review;Journal of Market Access & Health Policy;2023-10-04

4. Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry;European Journal of Heart Failure;2023-09-18

5. Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial);ESC Heart Failure;2023-07-10